DDX3X and pancreatic neoplasm: Our approach involved the use of lentiviral short-hairpin RNA (shRNA) to stably silence DDX3X expression in a variety of pancreatic cancer cell lines, namely, MIA PaCa-2, PANC-1, SW1990, AsPC-1, and CFPAC-1.